SABCS 2022 : Genetic Profiling (POLAR) for Patients with BC may Safely Omit Radiation

SABCS 2022 - Race and Clinical Outcomes in the RxPONDER Trial

ESMO 2022 - TROPiCS-02: Final results phase III study in MBC

ASCO 2022 - MAINTAIN Trial of Fulvestrant/Exemestane +/- Ribociclib After Progression in mBC

ASCO 2022 - DESTINY-Breast04 trial in HER2-low unresectable and/or metastatic breast cancer